** Shares of drugmaker Vericel VCEL.O fall 12.7% to $51.25 in extended trading
** VCEL expects prelim Q4 revenue in the range of about $75.2 million to $75.7 million
** Analysts estimate Q4 revenue of $77.93 mln on average -data compiled by LSEG
** VCEL expects Q4 gross margin to be ~77% vs estimates of 75.43%
** Co expects 20% to 23% total revenue growth for 2025
** As of Dec 31, 2024, co had ~$167 million in cash, restricted cash and investments, and no debt - VCEL
** Up to last close, stock gained ~53% over the past 12 months
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))